Small Caps Surge on Biotech and Energy News
By ATTN Desk · Editorial oversight: Sean Han
Daily Market Recap – June 17, 2025
Stock‐trading activity on June 17 saw broad gains across small- and micro-cap equities, driven largely by speculative interest in clinical-stage biotech names and renewed buying in sub-$1 issues. Volume surged in several tickers, reflecting investors’ search for high‐beta opportunities amid a mixed macroeconomic backdrop.
Key Price Table
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| SDST | $0.1320 | $0.1848 | 25,820,085 | +40.00% |
| SAFX | $1.0632 | $2.0200 | 9,407,963 | +89.99% |
| SEDG | $13.571 | $16.0500 | 22,608,780 | +18.28% |
| ACXP | $0.4541 | $0.7530 | 219,694,957 | +65.75% |
| SLRX | $0.7955 | $1.1900 | 21,688,087 | +49.70% |
| VERV | $10.594 | $11.2300 | 54,759,431 | +5.99% |
| CERO | $6.585 | $17.1600 | 37,373,597 | +160.77% |
| INEO | $1.0425 | $1.5200 | 11,989,873 | +45.86% |
| BPT | $0.5167 | $0.6459 | 875,554 | +25.00% |
| BGSF | $4.627 | $5.4601 | 906,991 | +18.04% |
| PCSA | $0.0690 | $0.2707 | 387,315,091 | +292.70% |
| RDW | $15.26 | $16.7500 | 10,253,009 | +9.80% |
| RBNE | $5.42 | $11.7200 | 30,059,898 | +116.27% |
| APPS | $4.983 | $7.4400 | 56,104,693 | +49.33% |
| EYEN | $2.430 | $6.5200 | 21,344,224 | +168.30% |
| RUN | $5.081 | $5.7699 | 83,954,219 | +13.57% |
| WTF | $4.178 | $6.3500 | 401,931 | +52.04% |
| MSW | $2.449 | $4.3500 | 340,771 | +77.57% |
| GALT | $1.379 | $2.5000 | 8,759,380 | +81.15% |
| CGTL | $1.684 | $2.0300 | 3,660,039 | +20.54% |
Market Analysis
Trading focused on biotech and alternative-energy names, where clinical announcements and funding updates sparked rapid re-rating. Yesterday’s laggards led the charge higher, with many sub-$2 stocks more than doubling on heavy turnover. Volume leaders included ACXP and PCSA, each attracting hundreds of millions of shares as speculative flows rotated into beaten-down issues.
Sectorwide, small caps outperformed larger benchmarks, underlining the appetite for high-volatility plays. Green-energy tickers SAFX and SEDG both posted strong moves after capacity expansion news and robust order pipelines, while fintech and digital-services stocks like APPS saw renewed interest on valuation pullbacks.
Highlights of the Session
- PCSA (+292.7%) traded over 387 million shares after announcing a $5 million financing round to advance oncology trials.
- CERO (+160.8%) climbed on FDA approval news for its lead compound, sending volume above 37 million shares.
- EYEN (+168.3%) jumped following reports of merger talks and a pending device submission, driving turnover to 21 million.
- RBNE (+116.3%) more than doubled as investors reacted to a strategic spin-off announcement and improved charter-rate forecasts.
- SAFX (+89.99%) and GALT (+81.15%) saw sizable gains in the sustainable-fuel and mining sectors, respectively, amid favorable policy commentary.
Meanwhile, more established names such as VERV and RUN registered modest advances, suggesting a broad-based uptick rather than a narrow rally. Overall market breadth was positive, with advances outnumbering decliners by roughly 4:1 among the stocks covered.
TL;DR
- Small- and micro-caps led gains on June 17, driven by biotech and energy news.
- PCSA, CERO, EYEN and RBNE each surged over 100% on funding, FDA and corporate-action developments.
- Volume concentrated in speculative, sub-$2 issues, with multiple names trading tens to hundreds of millions of shares.
- Broad participation underpinned a strong session for lower-priced equities, as traders chased high-beta opportunities.